Cita APA

Offidani, M., Corvatta, L., Morè, S., Nappi, D., Martinelli, G., Olivieri, A., & Cerchione, C. (2021). Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments. Front Oncol.

Chicago Style Citation

Offidani, Massimo, Laura Corvatta, Sonia Morè, Davide Nappi, Giovanni Martinelli, Attilio Olivieri, i Claudio Cerchione. "Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments." Front Oncol 2021.

Cita MLA

Offidani, Massimo, et al. "Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments." Front Oncol 2021.

Atenció: Aquestes cites poden no estar 100% correctes.